Chemomab Therapeutics

(NSC:ANCN) Trade

Symbol has changed to a new ticker symbol


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Chemomab Therapeutics Ltd is a pivotal-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of novel therapeutics for fibrosis-related diseases.

Contact Information

Main Phone: +972 25486555
Address: Kiryat Atidim, Building 7
Address 2: P.O. Box 45032, Har Hotzvim
City / Town: Tel Aviv
Country: IL
Postal Code: 6158002

Issuer Information

Exchange: NSC
CEO: Neil Cohen
Employees: 3
NAICS: Offices of Physical, Occupational and Speech Therapists, and Audiologists(621340)

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A